Cefuroxime (2nd Gen) Tablets/capsules Generics - Manufacturers & Suppliers
Ceftin, Zinacef(US & EU)
| Product/Composition:- | Cefuroxime (2nd Gen) Tablets/Capsules |
|---|---|
| Strength:- | 250 mg, 500 mg |
| Form:- | Oral Tablets/Capsules |
| Reference Brands:- | Ceftin, Zinacef(US & EU) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Cefuroxime inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, leading to bacterial lysis. It is effective against respiratory, urinary, skin, and soft tissue infections. Benefits include broad-spectrum activity, rapid bacterial eradication, and oral administration, making it a reliable choice for treating common bacterial infections when used appropriately.
Cefuroxime (2nd generation cephalosporin) tablets and capsules are approved in both the EU and US for treating respiratory, urinary, and skin bacterial infections. In the EU, brands like Ceftin and Zinacef are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic formulations are widely available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans. For regulatory support, compliance, and registration, visit PharmaTradz. We support seamless market access for cefuroxime, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.